Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
Arcadia Biosciences reports 2021 executive compensation
By ExecPay News
Published: April 19, 2022
Arcadia Biosciences reported fiscal year 2021 executive compensation information on April 19, 2022.
In 2021, four executives at Arcadia Biosciences received on average a compensation package of $740K, a 35% increase compared to previous year.
Average pay of disclosed executives at Arcadia Biosciences
Matthew Plavan, Chief Executive Officer, received $1.6M in total, which increased by 102% compared to 2020. 51% of Plavan's compensation, or $814K, was in option awards. Plavan also received $82K in non-equity incentive plan, $444K in salary, as well as $267K in other compensation.
Chris Cuvelier, Chief Growth Officer, received a compensation package of $536K. 42% of the compensation package, or $227K, was in option awards.
Pamela Haley, Chief Financial Officer, earned $474K in 2021, a 7% increase compared to previous year.
Laura Pitlik, Chief Marketing Officer, received $343K in 2021.
Related executives
You may also like
Source: SEC filing on April 19, 2022.